Please provide your email address to receive an email when new articles are posted on . Among pediatric patients in the Pediatric Pulmonary Hypertension Network, nearly half had group 3 disease, ...

Both the cause and a potential cure for the most common identifiable and specifically treatable cause of hypertension – aldosterone-producing adenomas (APAs) – have been revealed by researchers from ...

Young-onset hypertension increases the risk of cardiovascular and kidney outcomes compared with late-onset hypertension in type 2 diabetes.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with both hypertension and type 2 diabetes had ...

Concurrent hypertension and type 2 diabetes was associated with significantly higher mortality risks than either condition alone among US adults. Concurrent hypertension and type 2 diabetes (T2D) is ...

May 27, 2025-- U.S. adults with both hypertension and Type 2 diabetes (T2D) face a significantly higher risk of all-cause and cardiovascular mortality compared to those with only one of these ...

Active ingredient: Riociguat 0.5 mg, 1 mg, 1.5 mg, 2 mg, 2.5 mg; tabs. Indication: Treatment of persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) (WHO Group 4) after surgical ...

In more than 15% of people with benign adrenal tumors, the growths produce clinically relevant levels of serum cortisol that are significantly linked with an increased prevalence of hypertension and, ...

L-type calcium channel blockers (LCCBs) -- the most widely used drugs for treating hypertension -- may harm the heart as much as help it, according to a new study. The research team, led by Penn State ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...